Evidence map›Paper›PMID 40143033›Full record

ArticlePharmaceutics2025

Improved Photodynamic Therapy of Hepatocellular Carcinoma via Surface-Modified Protein Nanoparticles.

Ahmed M Abdelsalam, Amir Balash, Shaimaa M Khedr, Muhammad Umair Amin, Konrad H Engelhardt, Eduard Preis, Udo Bakowsky

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ahmed M AbdelsalamDepartment of Pharmaceutics and Biopharmaceutics, University of Marburg, Robert-Koch Straße 4, 35037 Marburg, Germany.
Amir BalashDepartment of Pharmaceutical Chemistry, University of Marburg, Marbacher Weg 10, 35032 Marburg, Germany.ORCID 0009-0002-8032-5982
Shaimaa M KhedrPharmaceutical and Fermentation Industries Development Center (PFIDC), City of Scientific Research and Technology Applications (SRTA-City), New Borg El Arab 21111, Egypt.
Muhammad Umair AminDepartment of Pharmaceutics and Biopharmaceutics, University of Marburg, Robert-Koch Straße 4, 35037 Marburg, Germany.
Konrad H EngelhardtDepartment of Pharmaceutics and Biopharmaceutics, University of Marburg, Robert-Koch Straße 4, 35037 Marburg, Germany.
Eduard PreisDepartment of Pharmaceutics and Biopharmaceutics, University of Marburg, Robert-Koch Straße 4, 35037 Marburg, Germany.ORCID 0000-0003-2112-8436
Udo BakowskyDepartment of Pharmaceutics and Biopharmaceutics, University of Marburg, Robert-Koch Straße 4, 35037 Marburg, Germany.ORCID 0000-0002-3895-0453

Funding

German Academic Exchange Service n/a
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

active targetingglycyrrhetinic acidHepG2parietinPEGylationphotosensitizertargeted drug deliveryzein

Identifiers

PMID40143033
PMCPMC11944767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.